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Abstract 28 
Introduction: Caffeine is a well-established performance enhancing nutritional supplement in a young 29 
healthy population, however far less is known about how its ergogenicity is affected by increasing 30 
age. A recent review has highlighted the value of studies examining the direct effect of caffeine on 31 
isolated skeletal muscle contractility, but the present work is the first to assess the direct effect of 32 
70µM caffeine (physiological maximum) on the maximal power output of isolated mammalian 33 
muscle from an age range representing developmental to early ageing. Method: Female CD1 mice 34 
were aged to 3, 10, 30 and 50 weeks (n = 20 in each case) and either whole EDL or a section of the 35 
diaphragm was isolated and maximal power output determined using the work loop technique. Once 36 
contractile performance was maximised, each muscle preparation was treated with 70µM caffeine and 37 
its contractile performance was measured for a further 60 minutes. Results: In both mouse EDL and 38 
diaphragm 70µM caffeine treatment resulted in a significant increase in maximal muscle power 39 
output that was greatest at 10 or 30 weeks (up to 5% & 6% improvement respectively). This 40 
potentiation of maximal muscle power output was significantly lower at the early ageing time point, 41 
50 weeks (up to 3% & 2% improvement respectively), and in mice in the developmental stage, at 3 42 
weeks of age (up to 1% & 2% improvement respectively). Conclusion: Uniquely, the present findings 43 
indicate a reduced age specific sensitivity to the performance enhancing effect of caffeine in 44 
developmental and aged mice which is likely to be attributed to age related muscle growth and 45 
degradation, respectively. Importantly, the findings indicate that caffeine may still provide a 46 
substantial ergogenic aid in older populations which could prove important for improving functional 47 
capacity in tasks of daily living.       48 
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Introduction 53 
The ergogenic benefit of caffeine to promote performance enhancing effects has been extensively 54 
studied and it is well recognised that caffeine induces increases in endurance, strength and power 55 
performance in young healthy participants [see reviews 6, 16, 23]. Given that large amounts of 56 
caffeine are consumed by a broad age range of people in western societies, there is surprisingly little 57 
evidence examining how the ergogenicity of this drug is affected by age. However, with an 58 
increasingly aged population whose decline in skeletal muscle function affects performance in 59 
everyday tasks [60], research is warranted to examine the age specific sensitivity of skeletal muscle to 60 
the direct performance enhancing effects of caffeine. 61 
Norager et al. [41] was one of the first studies to examine the effect of acute caffeine supplementation 62 
on exercise performance in an elderly population. The study reported a significant increase in cycling 63 
endurance (25%), arm flexion endurance (54%) and associated reduction in RPE in men and women 64 
aged over 70 following 6mg/kg caffeine consumption. No significant differences were found in 65 
muscle strength, walking speed, or reaction time. Interestingly, Norager et al, [41] reported that the 66 
increase in arm flexion endurance was markedly higher than that seen in an earlier study on younger 67 
individuals. This suggests that caffeine may prove to be more ergogenic in an older adult population. 68 
In support of this notion, Swift and Tiplady [52] further concluded that the elderly may be more 69 
sensitive to the effects of caffeine at the psychomotor level with this population showing greater 70 
improvements in attention and choice reaction time compared to younger participants. Duncan et al, 71 
[20] demonstrated that low dose (3mg/kg) caffeine improved six minute walk distance, 8 foot up and 72 
go time, number of arm curl reps completed in 30 seconds and manual dexterity in participants aged 73 
66 years. Subsequently Duncan et al, [20] concluded that caffeine could be used as an effective 74 
nutritional supplement for improving functional performance in the elderly.  In agreement, Momsen et 75 
al, [39] demonstrated a significant increase in maximal walking distance (20%) and maximal 76 
isometric knee extension strength (9.8%) following 6 mg/kg caffeine supplementation in 68 year old 77 
patients with moderate intermittent claudication. Conversely, evidence suggests that a caffeine 78 
induced increase in muscular strength of elderly participants is not always reported [54]. This 79 
relatively small quantity of research and the ambiguity in findings warrant further more controlled 80 
research examining the relationship between the performance enhancing effects of caffeine and 81 
increasing age. 82 
A recent review by Tallis et al, [53] has highlighted the value of isolated mammalian muscle studies 83 
for examining the direct performance enhancing effect of caffeine. As the mechanism of enhanced 84 
performance has in part been attributed to the direct action of caffeine to promote an increase in 85 
muscle function [37], such in vitro studies allow the direct assessment of caffeine on skeletal muscle 86 
without interference from other central and physiological processes. More importantly digestion and 87 
distribution, habituation, withdrawal effects, side effects of high dose caffeine consumption and 88 
motivation to complete repeated maximal exercise, that are factors difficult to control in human 89 
studies, are not prevalent in isolated muscle work. Such aspects have been suggested to result in an 90 
individual caffeine response subsequently resulting in a number of equivocal findings in the human 91 
literature [53]. The same limitations affect the relatively small amount of literature examining the 92 
effect of caffeine on performance in older human participants and subsequently warrant the use of 93 
isolated muscle studies to get a clearer indication of the effectiveness of this drug in such populations. 94 
Previous work, using isolated muscles from young healthy rodents, has demonstrated that high (mM), 95 
and more recently, physiologically relevant (50-70µM) concentrations of caffeine can cause a 96 
significant fibre type specific improvement in the maximal force and power producing properties of 97 
skeletal muscle [3, 28, 29, 55, 56]. Mechanistically this has been attributed to the action of caffeine as 98 
an adenosine receptor antagonist acting specifically at the A1 receptors on the skeletal muscle 99 
membrane and/or its ability to bind to ryanodine receptors (RYR) of the sarcoplasmic reticulum (SR) 100 
[14, 21, 46]. The net effect is an improvement in excitation contraction coupling promoting greater 101 
SR Ca2+ release, and as a consequence, a more forceful contraction [23, 33, 55]. An increase in age is 102 
associated with a reduction in the efficacy of the excitation contraction coupling process and altered 103 
Ca2+ handling properties as a mechanism for the age related loss of muscle function [17, 40]. These 104 
age related changes in E-C coupling may significantly reduce the skeletal muscle response to caffeine 105 
treatment and mechanistically would appear to contradict the increased caffeine sensitivity proposed 106 
by Norager et al, [41]. 107 
The present study builds on our previous body of work (reviewed in [53]) and is the first to assess the 108 
direct effects of a physiologically relevant concentration of caffeine (70µM, maximal for human 109 
consumption; [21]) on mammalian skeletal muscle performance in a large age range of individuals. 110 
Specifically our aim was to measure the maximal power output of isolated mouse EDL 111 
(predominantly fast-twitch) and diaphragm (mixed muscle fibre type) skeletal muscles over an age 112 
range from ‘developmental’ (3 weeks old) to ‘early aged’ (50 weeks old). Previous evidence has 113 
demonstrated that 50 week old CD1 mice show a substantial age related decline in skeletal muscle 114 
mechanical performance [57] and were subsequently deemed appropriate for use in the context of this 115 
study. Moreover, the present work is the first (in vivo or in vitro) study to examine the ergogenic 116 
effect of caffeine over a broad range of ages, rather than just examining older adults or younger adults 117 
as in previous human work [6, 20, 23, 41, 56]. By using the work loop technique to examine different 118 
muscles, the present study will be able to establish fibre type specific effects of caffeine on the 119 
mechanical properties of muscle in relation to age using a method that better simulates real life 120 
muscle function than more commonly used in vitro tests [27, 30, 31, 32].  In addition, the ergogenic 121 
effect of caffeine on exercise performance has not been studied in children and adolescents despite the 122 
high consumption of caffeinated products in this population [5]. The present study will offer an 123 
important insight into the direct effects of caffeine in juvenile and elderly populations. 124 
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Methods 131 
Animals 132 
Female white mice (strain CD1 mice, Charles River, UK) were bred and kept in house at Coventry 133 
University. This study was approved by the Coventry University ethics committee. The assessment of 134 
the age related direct effect of caffeine was conducted on mice aged 3, 10, 30 and 50 weeks old (n=20 135 
in each case). From birth animals were kept in groups of 8 without access to running wheels. The 136 
rationale for the use of animals at these age groups to examine the ageing effect on mechanical 137 
performance of skeletal muscle is given in our previous work [57] but can be summarised as follows 138 
for both EDL and diaphragm: At 3 weeks of age mice are weaned and muscle performance is low, at 139 
10 weeks muscle performance peaks, at 30 weeks the onset of ageing begins and by 50 weeks there is 140 
a substantial age related reduction in the maximal force and power generating capacity of various 141 
skeletal muscles. 142 
Dissection 143 
Mice were weighed to the nearest 0.1g on an electronic balance (body mass (g):  3 weeks = 15.8 ± 144 
1.2; 10 weeks = 31.9 ± 0.8; 30 weeks = 41.6 ± 0.8; 50 weeks 58.2 ± 5.4; mean ± SE, n=20 in each age 145 
group).  Mice were then killed by cervical dislocation in accordance with the British Home Office 146 
Animals (Scientific Procedures) Act 1986, Schedule 1. Either a ventral section of the costal 147 
diaphragm or an EDL muscle was dissected from each mouse in cooled (4-6°C) oxygenated (95% O2; 148 
5% CO2) Krebs-Henseleit solution of composition (mM) NaCl 118; KCl 4.75; MgSO4 1.18; NaHCO3 149 
24.8; KH2PO4 1.18; glucose 10; CaCl2 2.54; pH 7.55 at room temperature prior to oxygenation. As a 150 
method to prevent tendon slippage during muscle force production, aluminium foil T-clips were 151 
wrapped around each tendon of the EDL. The central section of the left hand half of the diaphragm 152 
muscle was prepared in a similar fashion, however at one end the two ribs that anchored the muscle 153 
were left intact. 154 
Experimental Set-Up 155 
Using either the aluminium foil T-clips or bone, each muscle preparation was connected via crocodile 156 
clips to a force transducer at one end (UF1, Pioden Controls Ltd, Kent, UK) and a motor at the 157 
opposing end (V201, Ling Dynamic Systems, Hertfordshire, UK). Position of the motor arm was 158 
detected via a Linear Variable Displacement Transformer (DFG5.0, Solartron Metrology, Sussex, 159 
UK). The muscle was maintained in circulated oxygenated Krebs-Henseleit solution at a constant 160 
temperature of 37oC. The muscle was electrically stimulated to produce force via parallel platinum 161 
electrodes inside the muscle chamber. These electrodes were not directly in contact with the muscle or 162 
the nerve branch but caused activation by stimulating the surrounding fluid. Muscle stimulation and 163 
length change parameters were controlled using custom written software (Testpoint, CEC, 164 
Massachusetts, USA) via a D/A board (KPCI3108, Keithley Instruments, Ohio, USA) on a desktop 165 
PC. Each muscle preparation went through a series of isometric muscle tests followed by assessments 166 
of work loop power. 167 
Isometric Testing 168 
Initially twitch force was assessed by electrically stimulating the muscle whilst held at a constant 169 
length. The muscle length and stimulation amplitude (14-18V for EDL; 10-16V for diaphragm) were 170 
optimised to produce maximal twitch force. The muscle length that corresponded with maximal 171 
twitch force was measured using an eyepiece graticule and defined as L0. Similarly to James et al 172 
[27], mean muscle fibre length was calculated as 75% of L0 for EDL muscle. As no such estimate of 173 
fibre length exists for diaphragm the direct measurement taken was used as L0 [57].  Each muscle was 174 
then subjected to a 250ms burst of electrical stimulation in order to produce a tetanus response. 175 
Stimulation frequency was optimised in order to produce maximal tetanus force (usually 200Hz for 176 
EDL and 140Hz for diaphragm; this was not affected by age). A 5 minute rest period was imposed 177 
between each tetanus in order to allow the muscle sufficient recovery between stimulations. 178 
The Work Loop Technique 179 
The work loop technique was employed as a method of providing a closer representation of in vivo 180 
skeletal muscle performance [31]. Similarly to in vivo muscle function, this method considers that 181 
muscle cannot shorten indefinitely and must go through a period of re-lengthening before subsequent 182 
contraction. The work loop technique employs cyclical length changes using waveforms and 183 
stimulation parameters that more closely approximate those used in vivo to assess the ability of the 184 
muscle to produce dynamic power [28, 30, 31, 32]. 185 
Essentially the approach used for EDL and diaphragm was the same as that used in our previous study 186 
on ageing [57]. The muscle was held at the previously determined L0 and the stimulation amplitude 187 
and stimulation frequency parameters that yielded maximal tetanic force were employed. Each muscle 188 
was subjected to four sinusoidal length change cycles per set at a total symmetrical strain of 0.10, as 189 
this strain has been used previously to elicit maximal power output in these muscles [27, 55, 57]. As 190 
such, the muscle lengthened by 5% from L0 followed by a shortening to 5% shorter than L0 before 191 
returning back to L0. A cycle frequency of 10Hz and 7Hz was used for EDL and diaphragm muscle 192 
respectively. 10Hz represents the cycle frequency that has previously been shown to elicit maximal 193 
power output in EDL [27]. 7Hz represents the cycle frequency that elicited maximal power output in 194 
diaphragm in preliminary work by the authors and is similar to previous findings [4]. The magnitude 195 
and frequency of length changes and electrical stimulation were controlled via the Testpoint software. 196 
Data were sampled at a rate of 10 kHz and then a work loop was formed, by plotting force against 197 
length, the area of which represents the net work done by the muscle during a single length change 198 
cycle [31]. Stimulus burst duration (stimulation primarily through shortening) was altered until 199 
maximal net power output was achieved. 200 
Usually a 49 ms burst duration was used for EDL which is in keeping with that previously used at 201 
10Hz cycle frequency [27, 57]. The burst duration commonly used to elicit maximum power output in 202 
diaphragm muscle was 55 ms, similar to our previous work [57]. On occasions the burst duration had 203 
to be increased or decreased to adjust the number of stimuli given. This was determined by examining 204 
the work loop power output and by interpretation of the work loop shapes. e.g. if the muscle is too 205 
active during re-lengthening it will significantly distort the shape of the loop and reduce muscle power 206 
output by increasing the resistance of the muscle to stretch. A stimulation phase shift of -2 ms and -5 207 
ms were used for EDL and diaphragm respectively, as they corresponded with maximal power output, 208 
in agreement with our previous work [57]. So for EDL this stimulation phase shift value dictates that 209 
stimulation of the muscle starts 2 ms prior to the muscle reaching maximal length. 210 
The Effect of 70µM Caffeine Treatment 211 
Each muscle was subjected to a set of 4 work loop cycles every ten minutes over a 130 minute 212 
duration [28, 55, 57]. Three measurements of the muscles maximal power output were made in 213 
standard Krebs-Henseleit solution and this formed the initial control baseline measurement. Following 214 
this the circulating fluid was changed to Krebs containing 70µM caffeine and a further 6 215 
measurements of maximal power output were made. The assessment concluded with a washout period 216 
where the circulating fluid was replaced with standard Krebs and a further 4 measurements of 217 
maximal power were taken, the latter three of which were used to represent the washout control. 218 
Muscle Mass Measurements and Dimension Calculations 219 
At the end of the experiment the muscle was removed from the clips and the tendons were removed 220 
leaving the whole muscle intact. The muscle was then blotted on absorbent paper to remove excess 221 
fluid. The muscle was then placed on an electronic balance (Mettler Toledo B204-S, Zurich, 222 
Switzerland) to determine the wet muscle mass to the nearest 0.0001g. Mean muscle cross-sectional 223 
area was calculated from mean fibre length (muscle length in the case of diaphragm), muscle mass 224 
and an assumed muscle density of 1060 kg m-3 [38]. Isometric stress was calculated as maximal 225 
tetanic force divided by mean muscle cross-sectional area. Muscle power output was normalised to 226 
muscle mass to express power as W.kg-1. 227 
Statistical Analysis of the Data 228 
In control conditions muscle power output will decrease over time due to the gradual development of 229 
an anoxic core [8]. Over the 130 minute duration of the protocol used in the present study, muscle 230 
power output had decreased to 92.5±0.61% of initial power output. In order to avoid the given 231 
deterioration in muscle power output masking the effects of the caffeine treatment, a 1st order 232 
regression equation was calculated using the pre-treatment control data and post treatment washout 233 
control data to identify the linear relationship between muscle power output and time. This regression 234 
equation was then used to determine theoretical control muscle power output for each time point 235 
during caffeine treatment [28, 55]. 236 
Initially for each treatment group, pre-treatment controls were compared directly against post 237 
treatment washout controls using a paired t-test. There was no significant difference between these 238 
measurements (Paired T-test p>0.7 in each individual case) therefore these results were pooled to 239 
form controls. Thereafter, it was assumed that any subsequent change in muscle power output was 240 
solely the effect of the given caffeine treatment. Consequently controls were compared directly 241 
against caffeine treatment using a further paired T-test for each treatment group. To establish whether 242 
a difference in the effect of caffeine occurred between ages a single factor ANOVA was conducted on 243 
the caffeine treatment data, after normalisation as a percentage of the theoretical control, for each of 244 
EDL and diaphragm muscle respectively. When the ANOVA indicated a significant difference 245 
between age groups, Tukey post hoc tests were used to identify where these differences occurred. An 246 
independent samples t-test was conducted to compare the caffeine treatment results for EDL and 247 
diaphragm of the same age group in order to identify whether the ergogenic benefit was greater in a 248 
particular muscle at each age. 249 
As the caffeine response was not uniform within each treatment group and EDL muscle mass was 250 
significantly affected by age (ANOVA p<0.001), we considered it valuable to determine if the 251 
caffeine effect was affected by muscle mass. This relationship was determined by using Pearson’s two 252 
tailed correlation analysis for these data for each treatment group. 253 
Results were interpreted as significant when p < 0.05. Values are displayed as mean ± standard error. 254 
 255 
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 259 
Results 260 
The Effect of 70µM Caffeine Treatment on the Maximal Power Output of Mouse EDL 261 
Treatment of mouse EDL with 70µM caffeine resulted in a significant increase in power output by up 262 
to 1%, 4%, 5% and 3% for 3, 10, 30 and 50 week old mice respectively  (Fig 1; paired t-test p<0.001 263 
between control and caffeine power output in all cases). There was a significant effect of age on the 264 
caffeine induced improvement in power output (ANOVA p<0.001). The caffeine induced increase in 265 
muscle PO was the highest at 30 weeks and was significantly greater than the response at 3 and 50 266 
weeks (Fig 1; Tukey p<0.001 in both cases) and had a tendency to be greater than that at 10 weeks 267 
(Fig 1; Tukey p=0.079). The ergogenic benefit at 3 weeks was significantly lower than at all other 268 
ages (Fig 1; Tukey p<0.005 in all cases). The increase in muscle PO at 10 weeks did not prove to be 269 
significantly different to that at 50 weeks (Fig 1; Tukey p=0.733). 270 
The Effect of 70µM Caffeine Treatment on the Maximal Power Output of Mouse Diaphragm 271 
Treatment of mouse diaphragm with 70µM caffeine resulted in a significant increase in power output 272 
by up to 2%, 6%, 4%, and 2% for 3, 10, 30 and 50 week old mice respectively  (Fig 2; paired t-test 273 
p<0.001 in all cases). There was a significant effect of age on the caffeine induced improvement in 274 
power output (ANOVA p<0.005). The caffeine induced increase in power output at 10 weeks was the 275 
highest and was significantly greater than at 3, 30 and 50 weeks (Fig 2; Tukey p<0.004 in all cases). 276 
Power output was also significantly higher at 30 weeks compared to 3 weeks and 50 weeks (Fig 2; 277 
Tukey p<0.02 in both cases). There was no significant difference in power output between 3 weeks 278 
and 50 weeks (Fig 2; Tukey p=0.864). 279 
The ergogenic benefit of 70µM caffeine treatment was significantly greater in EDL muscle compared 280 
to diaphragm at 30 and 50 weeks (Fig 3; two-sample t-test p<0.005 in both cases). The caffeine 281 
induced potentiation of diaphragm power output had a tendency to be greater than EDL at 10 weeks 282 
(two-sample t-test p=0.054). The caffeine induced increase in maximal muscle power output at 3 283 
weeks was not significantly different between muscles (independent samples t-test p=0.54). 284 
The Effect of 70µM Caffeine Treatment in Relation to Muscle Mass 285 
EDL muscle mass was significantly affected by age (ANOVA p<0.001). Muscle mass at 3 weeks 286 
(0.00672 ± 0.00171g), was significantly lower than that at 10 (0.01244 ± 0.00038g), 30 (0.01422 ± 287 
0.00023g), and 50 (0.00245 ± 0.00078g) weeks (Tukey p<0.001 in all cases). Muscle mass at 30 and 288 
50 weeks was significantly greater than that at 10 weeks (Tukey p<0.001). Similar comparisons for 289 
diaphragm cannot be made due to usage of only part of the diaphragm. There was no significant 290 
relationship between whole EDL muscle mass, or the mass of the diaphragm strip, used in the 291 
assessment of muscle mechanics and the performance enhancing benefit of caffeine for any of the 292 
experimental groups (Table 1; p>0.07 in all cases). Therefore, as all of our power output values are 293 
expressed relative to control muscle power output the variation in muscle mass between preparations 294 
should not need to be further accounted for in our analysis. 295 
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Discussion 308 
The Direct Effect of 70µM Caffeine on Aged Skeletal Muscle 309 
The present findings are the first to demonstrate that 70µM caffeine can directly potentiate skeletal 310 
muscle power output across a broad range of ages and subsequently adds further evidence to the small 311 
body of human research that suggests that caffeine could be used as an effective performance 312 
enhancing nutritional supplement in older adult populations [20, 39]. The present work is the first to 313 
assess how the sensitivity of the caffeine effect on exercise changes with age. The results demonstrate 314 
that the magnitude of the performance enhancing effect is influenced by age and muscle fibre type 315 
composition. The caffeine induced potentiation of both EDL and diaphragm muscle power output was 316 
significantly reduced in the oldest and youngest age groups compared to the younger adult groups. 317 
The caffeine induced increase in EDL muscle power output at 10 weeks of age (up to 4%) is 318 
consistent with the 3% reported by James et al, [28] and Tallis et al, [55] using similar experimental 319 
methods. However, caffeine treatment caused the greatest increase in muscle power output at 30 320 
weeks of age. This is particularly interesting given that the onset of the early age related decline in 321 
contractile performance has been demonstrate to occur at 30 weeks of age in this strain of mice (see 322 
[57] for a full report of the effect of increasing age on mechanical performance of skeletal muscle 323 
used in this study). The present work is the first to assess the direct effect of 70µM caffeine on 324 
diaphragm muscle and the 6% increase in muscle power is comparable to that previously reported for 325 
mouse soleus [55]. In mice both soleus and diaphragm have previously been shown to be composed of 326 
more aerobic fibres than EDL [1, 7]. Unlike in EDL, an increase in age beyond that associated with 327 
peak mechanical performance of diaphragm [57] caused a significant reduction in the magnitude of 328 
the caffeine effect. 329 
This age related reduction in skeletal muscle caffeine sensitivity occurs independently of changes in 330 
muscle mass (Table 1). One may speculate that the same absolute dose of caffeine may provide less of 331 
a benefit to larger muscles (as in the older age groups) due to a smaller concentration per area of 332 
tissue, but this did not prove to be the case. Therefore, it seems likely that skeletal muscle ageing may 333 
be accountable for this observed loss in the ergogenic effect in the oldest mice used in the present 334 
study. 335 
The rate of muscle activation and force production is primarily determined by effectiveness of 336 
excitation contraction coupling and the intramuscular Ca2+ transient time [9]. The demonstrated 337 
caffeine induced increase in maximal power output is likely to occur due to the effects of caffeine as a 338 
modifier of excitation-contraction coupling [23, 33]. Mechanistically, it is believed that caffeine acts 339 
as a direct agonist to adenosine receptors on the skeletal muscle membrane and has been demonstrated 340 
to bind to ryanodine receptors (RyR) of the sarcoplasmic reticulum (SR) [10, 14, 15, 21, 46]. It is 341 
likely that these actions result in an improved opening of RyR channels promoting a greater Ca2+ 342 
release into the intracellular space, an increased Ca2+ myofibrillar sensitivity, a decreased SR Ca2+ 343 
pump sensitivity and increased SR Ca2+ permeability. Consequently a reduction in the rate of Ca2+ 344 
efflux from the intracellular space back to the SR is likely to occur resulting in an elevated basal and 345 
subsequently activated intracellular Ca2+ concentration [2, 3]. Mechanical data from our previous 346 
work examining the effect of 70µM caffeine on the maximal power output of isolated skeletal muscle 347 
supports this, demonstrating an increase in work during the shortening phase of the work loop [55], 348 
and an increase in relaxation time and subsequent work required to re-lengthen the muscle at the end 349 
of the shortening phase during fatigue testing [56]. 350 
The age related reduction in the contractile performance of the muscles in the present study is 351 
believed to result from a reduction in the function of excitation-contraction coupling, as no substantial 352 
changes in either EDL or diaphragm fibre type composition or metabolic capacity were found 353 
between these same age groups in a previous study [57]. Renganathan et al, [45] demonstrated a 354 
significant age related reduction in SR Ca2+ release of rat EDL and soleus muscle attributed to DHPR-355 
RyR uncoupling. This was further supported by Delbono et al, [17] who confirmed a similar effect in 356 
fast fibres of human quadriceps muscle.  A reduction in the voltage gated SR Ca2+ release mechanism 357 
would result in a decreased Ca2+ availability for the contractile proteins and consequently a reduction 358 
in contractile force. Therefore, in the context of the present study, caffeine may still bind to RyR in 359 
the aged muscle but the age related uncoupling of DHPR-RyR may result in a decrease in the force 360 
and power enhancing effects of caffeine. In addition Larsson & Salviati [35] reported an age related 361 
reduction in SR Ca2+ concentration of fast twitch muscle of chemically skinned rats. As such it is 362 
likely that the reduction in the ergogenic properties of caffeine in aged muscle arise from a reduced 363 
ability to increase SR Ca2+ release.  364 
The Direct Effect of 70µM Caffeine on Developing Skeletal Muscle 365 
Despite the high consumption of caffeine in children, and caffeine containing products marketed 366 
specifically at this age group, the effect of caffeine on exercise performance in this population is not 367 
well understood [5]. Turley, Bland and Evans [58] reported limited effects of low, mild and high dose 368 
caffeine (1, 3 and 5 mg.kg-1) on physiological responses to exercise in 7-9 year old children. Caffeine 369 
treatment had no effect on substrate metabolism, however, mild and moderate dose caffeine treatment 370 
resulted in a slight increase in blood pressure and a slight decrease in heart rate. 371 
The present study shows that the treatment of muscle from 3 week old mice with 70µM caffeine has 372 
only a very small, but significant, effect on the potentiation of maximal work loop power output. The 373 
ergogenic benefit in this age group was not significantly different between diaphragm and EDL. 374 
Schiaffino and Margreth [48] and Luff and Atwood [36] established that at birth skeletal muscle SR is 375 
sparse and occurs as a loose network of tubes. Furthermore Luff and Atwood [36] demonstrated a 376 
muscle fibre type specific increase in mouse SR from 1.1% of fibre volume at birth to 5.5% in adult 377 
EDL (predominantly fast-twitch), and from 1.7% at birth to 2.9% in adult in soleus (predominantly 378 
slow-twitch). SR development occurred most rapidly in the initial 20 days and had reached adult 379 
values by 30 days in soleus and was still increasing after 60 days in EDL. Therefore it should be 380 
considered that in the 3-week-old diaphragm and EDL muscle used in present study, SR is not fully 381 
developed, thereby possibly limiting the action of caffeine on RYR and consequently reducing the 382 
level of caffeine induced Ca2+ release and subsequent force potentiating effects. 383 
In line with previous literature the present work infers that caffeine has limited effect on physiological 384 
responses to exercise and skeletal muscle performance in a pre-mature age group. However the 385 
stimulant effects at the central nervous system should be fully evaluated in vivo before conclusions are 386 
made about the value of caffeine as an ergogenic aid in children. Hughes and Hale [26] reported only 387 
slight improvements in vigilance performance and decreased reaction time in this population; 388 
however the effect of caffeine on the cognitive function of children requires further investigation. 389 
The Muscle Specific Action of 70µM Caffeine Treatment 390 
At 10 weeks of age the caffeine induced potentiation of maximal skeletal muscle power output was 391 
significantly greater in diaphragm muscle compared to EDL. However, beyond this the effect of 392 
caffeine was greater in aged EDL. It has been firmly established in adult rodent models that the force 393 
potentiating effects of caffeine are more greatly pronounced in muscle with a predominantly slower 394 
fibre type [22, 46, 55]. Although of mixed muscle phenotype, diaphragm will consist of a significantly 395 
greater proportion of oxidative muscle fibres than EDL which subsequently may explain why the 396 
caffeine induced benefit was greater in this muscle at 10 weeks of age (Figure 3). One may therefore 397 
argue that the widely reported age associated increase in type I fibre expression [18] would actually 398 
increase caffeine sensitivity. The likely absence of an age related change in fibre type expression in 399 
the muscles used in the present study, and the reported significantly greater loss in mechanical 400 
function in the diaphragm [57], likely explain why caffeine sensitivity was more dramatically reduced 401 
in this muscle. 402 
Irrespective of age the present study is the first to examine the direct effect of a physiologically 403 
relevant dose of caffeine on the mechanical performance of the diaphragm. Kivity et al, [34] 404 
demonstrated that high dose caffeine significantly improved the pre and post exercise forced 405 
expiratory volume in one second (FEV1) in healthy human male subjects, which was largely 406 
attributed to caffeine induced bronchodilation. In alignment with the work of Brinbaum and Herbst 407 
[11], these findings suggest that caffeine may evoke a significant increase in respiratory function 408 
across a range of ages which will have profound effects on exercise capacity by working to meet the 409 
oxygen demand of the active tissue. Our findings, combined with those of the previous studies suggest 410 
that caffeine may be effective in reducing the functional strain on patients with age associated 411 
respiratory diseases such as COPD. 412 
Practical Implications and Limitations of the Present Findings 413 
The present findings have used a more controlled approach to demonstrate that caffeine could be used 414 
as an effective nutritional supplement to directly improve muscle function across a broad range of 415 
ages. Although the magnitude of the effect was reduced in the older age groups, this small but 416 
significant benefit could still be effective in evoking meaningful improvements in functional 417 
performance. When the in vivo applications are considered, such increases in muscle power output are 418 
likely to transfer to an improved resistance to fatigue as caffeine treated muscles will be able to 419 
produce the same relative power output with a smaller number of recruited fibres.  420 
In line with our previous work the present results demonstrates an individual response to the caffeine 421 
treatment ranging between a 0-11% increase in power in the young adult group [55], however, the 422 
present study shows a lower effect, 0-5%, in the older adult group. These findings are particularly 423 
interesting given that individual responses have, in human literature, been attributed to caffeine 424 
habituation [49].  As this factor is not prevalent in a rodent model it appears that the individual 425 
responses to the performance enhancing effect of caffeine needs further investigation. The present 426 
results imply that there is no ‘one size fits all’ approach for maximising the caffeine response as some 427 
individuals may have a large increase in performance whilst others demonstrate little or no effect, 428 
regardless of previous caffeine exposure. 429 
In addition, caffeine has been shown to promote performance enhancing effects through its action as a 430 
central nervous system stimulant across a range of ages [23, 44]. This coupled with the increase in 431 
skeletal muscle performance reported in the present study could evoke more substantial increases in 432 
functional performance than that demonstrated by our present approach of examining the direct 433 
effects on skeletal muscle alone. 434 
Conceptually there is difficulty in relating the 70µM caffeine concentration used in the present work 435 
to quantities of oral caffeine consumption due to individual differences in the rate of caffeine 436 
metabolism [51], and the need to administer caffeine relative to body mass rather than as an absolute 437 
dose. Graham [23] stated that normal plasma caffeine concentrations range between 20-50µM and 438 
Van Soeren and Graham [59] demonstrated that 6 mg/kg caffeine consumption resulted in blood 439 
plasma level of ~50µM in athletes aged 37 years. Such moderate concentrations are used regularly in 440 
human literature, thus it is conceivable that a blood plasma concentration of 70µM can be achieved 441 
using high, but safe oral doses of caffeine. Our previous work using 10 week old mice has shown that 442 
caffeine induced improvements in contractility demonstrated at 70µM are still prevalent at 50µM 443 
[53]. There is no reason to assume that similar doses will not be equally effective in this ageing 444 
model.  445 
Despite findings demonstrating the benefits of caffeine consumption, the older adult population 446 
should exercise caution when consuming high quantities of caffeine. In some individuals, high doses 447 
of caffeine can lead to increased anxiety, gastrointestinal discomfort, and impairment of fine motor 448 
control [12, 50]. Evidence has demonstrated that daily consumption of high doses of caffeine will 449 
accelerate bone mineral density (BMD) loss in healthy postmenopausal women with calcium intakes 450 
below the recommended daily intake [25], however this has not been associated with an increased risk 451 
of bone fracture [24]. Although caffeine may increase blood pressure in non-habitual users, recent 452 
evidence demonstrated that heavy coffee consumption is not associated with an increased risk of 453 
coronary heart disease and that moderate consumption may actually negate this risk [13, 19]. 454 
Evidence further suggests that caffeine may have protective effects on late life cognitive decline, 455 
dementia [47, 42] and can act as a therapeutic tool in Parkinson’s disease [43]. 456 
The present work examines the caffeine response during early ageing, however future work should 457 
investigate skeletal muscle responses at the later extremities of older ageing. Although it may be 458 
considered that the performance enhancing benefit would decrease if the current trend is continued, an 459 
age related shift to a slower muscle fibre type composition could mitigate such a response.    460 
Conclusion 461 
The methods employed in the present study have allowed a more controlled investigation of how the 462 
direct performance enhancing effect of caffeine is affected by increasing age. Our results demonstrate 463 
that the direct treatment of skeletal muscle with, physiologically relevant, 70µM caffeine significantly 464 
potentiated the maximal power output of mouse EDL and diaphragm muscle independent of age. As 465 
such, caffeine may be used as an effective performance enhancing nutritional supplement in an older 466 
adult population. This is particularly significant given the equivocal findings reported in the small 467 
quantity of whole body human studies examining the effects of caffeine in the elderly. Interestingly 468 
however, our results are the first to demonstrate that the ability of caffeine to produce such effects is 469 
significantly reduced in this older age group, when compared to younger adults, which is likely to be 470 
related to the age related reduction in muscle function caused by a reduction in the efficiency of the 471 
excitation contraction coupling process. 472 
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 647 
Figure Legends 648 
Figure 1 – The effect of 70µM caffeine on the mean acute maximal power output of mouse EDL 649 
isolated from 3, 10, 30 and 50 week old mice [Data represented as mean ± SE: n=10 in each case). 650 
Figure 2 – The effect of 70µM caffeine on the mean acute maximal power output of mouse diaphragm 651 
isolated from 3, 10, 30 and 50 week old mice [Data represented as mean ± SE: n=10 in each case). 652 
Figure 3 - Comparison of the peak effect of caffeine on muscle power output, with increased age, 653 
between EDL and diaphragm [Each data point represented as mean ± SE: n=10 in each case]. 654 
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Table 1 – There was no relationship between caffeine treated peak power output and muscle mass  
  
Animal 3 Wk Mmass (g) 3 Wk PPO (%) 10 Wk Mmass (g) 10 Wk PPO (%) 30 Wk Mmass (g) 30 Wk PPO (%) 50 Wk Mmass (g) 50 Wk PPO (%) 
EDL 
1 0.0077 103.15 0.0126 110.67 0.0137 103.96 0.018 103.96 
2 0.0076 100.39 0.012 106.11 0.0136 109.21 0.0162 103.37 
3 0.0099 101.79 0.0129 100.63 0.014 104.76 0.0165 101.75 
4 0.0067 106.05 0.0133 107.89 0.0159 103.19 0.0152 103.78 
5 0.0085 103.02 0.0132 102.76 0.0142 105.82 0.0214 104.64 
6 0.0061 101.23 0.0111 105.12 0.0146 102.21 0.0155 104.06 
7 0.0048 102.00 0.0127 102.96 0.0143 107.57 0.0133 104.85 
8 0.0044 99.84 0.0098 102.59 0.0142 100.74 0.0137 101.44 
9 0.0058 100.45 0.0141 105.70 0.0145 110.06 0.0167 103.28 
10 0.0057 103.11 0.0127 102.93 0.0132 106.98 0.0134 105.48 
r value 0.233 0.168 -0.323 0.052 
P value 0.516 0.642 0.362 0.887 
Diaphragm 
1 0.0115 98.10 0.0176 111.52 0.0225 103.63 0.0369 101.80 
2 0.0098 104.88 0.0157 102.35 0.0147 108.63 0.0308 101.86 
3 0.0081 101.65 0.0187 101.65 0.015 102.48 0.0321 102.26 
4 0.0078 103.58 0.0132 106.67 0.024 103.78 0.0226 103.24 
5 0.0087 102.12 0.0131 106.20 0.0233 103.84 0.0298 98.78 
6 0.005 102.80 0.012 112.02 0.0251 104.40 0.025 103.51 
7 0.0071 101.14 0.0155 104.12 0.0264 103.99 0.0276 101.56 
8 0.0047 103.89 0.016 107.38 0.0281 102.60 0.0203 104.24 
9 0.0078 101.77 0.0159 104.95 0.0119 103.81 0.0264 101.77 
10 0.0066 101.90 0.0171 101.80 0.0195 100.66 0.022 103.51 
r value -0.465 -0.459 -0.231 0.593 
P value 0.176 0.183 0.521 0.071 
 
